FDA issues statement/update on Ozempic NAION risk by March 31, 2025
5
Ṁ100Ṁ415resolved Jan 12
Resolved
NO1H
6H
1D
1W
1M
ALL
Given international scrutiny of Ozempic's potential link to NAION, this market predicts whether the FDA will issue any formal statement or safety update specifically addressing NAION risk for Ozempic users by March 31, 2025. Resolution based on FDA website announcements.
References:
This question is managed and resolved by Manifold.
Market context
Get 
1,000 to start trading!
1,000🏅 Top traders
| # | Trader | Total profit |
|---|---|---|
| 1 | Ṁ47 | |
| 2 | Ṁ37 | |
| 3 | Ṁ13 | |
| 4 | Ṁ4 | |
| 5 | Ṁ0 |
People are also trading
Related questions
Ozempic approval is revoked or withdrawn before 2031
6% chance
Will Steve austad regularly try ozempic by EOY 2028
31% chance
Will Ozempic / semaglutide be FDA-approved for Alzheimer's before 2030?
28% chance
Will there be a recall of Wegovy/Ozempic before 2035?
75% chance
How much will Ozempic cost in 2027 in the USA?
Nobel Prize awarded for Ozempic (or GLP-1 drugs) by 2030?
38% chance
Will Matt Kaeberlein start taking semaglutide/ozempic by 2030?
41% chance
Will Ozempic/GLP-1 Agonists become an issue with a clear partisan divide in the US in the next 5 years?
45% chance
How many OECD countries will have court ordered semaglutide drugs (e.g., Ozempic) by the end of 2030
Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?
10% chance